Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.10.2023 | Case report

Cefiderocol/ciprofloxacin/colistin

Various toxicities, drug resistance and lack of efficacy: 15 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Wicky P-H, et al. Cefiderocol Treatment for Severe Infections due to Difficult-to-Treat-Resistant Non-Fermentative Gram-Negative Bacilli in ICU Patients: A Case Series and Narrative Literature Review. Antibiotics 12: No. 6, Jun 2023. Available from: URL: http://www.mdpi.com/journal/antibiotics Wicky P-H, et al. Cefiderocol Treatment for Severe Infections due to Difficult-to-Treat-Resistant Non-Fermentative Gram-Negative Bacilli in ICU Patients: A Case Series and Narrative Literature Review. Antibiotics 12: No. 6, Jun 2023. Available from: URL: http://​www.​mdpi.​com/​journal/​antibiotics
Metadaten
Titel
Cefiderocol/ciprofloxacin/colistin
Various toxicities, drug resistance and lack of efficacy: 15 case reports
Publikationsdatum
01.10.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-48308-5

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Camrelizumab

Case report

Methotrexate

Case report

Phenazopyridine

Case report

Multiple drugs

Case report

Atezolizumab